Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress

被引：0
|
作者：
Fujimoto, N. [1 ]
Aoe, K. [2 ]
Kozuki, T. [3 ]
Oze, I. [4 ]
Kato, K. [5 ]
Kishimoto, T. [1 ]
Hotta, K. [6 ]
机构：
[1] Okayama Rosai Hosp, Okayama, Japan
[2] Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan
[3] Shikoku Canc Ctr Hosp, Matsuyama, Ehime, Japan
[4] Aichi Canc Ctr, Res Inst, Nagoya, Aichi, Japan
[5] Kawasaki Med Coll, Okayama, Japan
[6] Okayama Univ Hosp, Okayama, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
programmed death-1; immune checkpoint inhibitor; asbestos;
D O I：
10.1016/j.jtho.2018.08.1265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-10
引用
收藏
页码：S746 / S746
页数：1
相关论文
共 50 条
  • [1] A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol
    Fujimoto, Nobukazu
    Aoe, Keisuke
    Kozuki, Toshiyuki
    Oze, Isao
    Kato, Katsuya
    Kishimoto, Takumi
    Hotta, Katsuyuki
    CLINICAL LUNG CANCER, 2018, 19 (05) : E705 - E707
  • [2] JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
    Miyamoto, Yosuke
    Kozuki, Toshiyuki
    Aoe, Keisuke
    Wada, Sae
    Harada, Daijiro
    Yoshida, Michihiro
    Sakurai, Jun
    Hotta, Katsuyuki
    Fujimoto, Nobukazu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [3] A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001
    Fujimoto, N.
    Kozuki, T.
    Aoe, K.
    Miyamoto, Y.
    Wada, S.
    Harada, D.
    Yoshida, M.
    Sakurai, J.
    Hotta, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1077 - S1077
  • [4] Radiation Recall Dermatitis after Pemetrexed Cisplatin chemotherapy in malignant pleural mesothelioma
    Berdel, C.
    Ruebe, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 7 - 7
  • [5] Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
    Skopljanac, Ivan
    Segrt, Ivana
    Mise, Kornelija
    Vukovac, Emilija Lozo
    Biocina, Anita Tolic
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Malignant pleural mesothelioma: maintenance chemotherapy with pemetrexed
    Nacci, A.
    Rizzo, P.
    Sponziello, F.
    Mazzoni, E.
    Fedele, P.
    Orlando, L.
    Schiavone, P.
    Calvani, N.
    Marino, A.
    Cinieri, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S833 - S833
  • [7] Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma - Czech Experience
    Kolek, Vitezslav
    Havel, Libor
    Pesek, Milos
    Salajka, Frantisek
    Koubkova, Leona
    Roubec, Jaromir
    Skrickova, Jana
    Sixtova, Dimka
    Hejduk, Karel
    Bortlicek, Zbynek
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S747 - S747
  • [8] Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed
    Hidetoshi Hayashi
    Isamu Okamoto
    Yasuko Ichikawa
    Masaki Miyazaki
    Hiroshige Yoshioka
    Kei Kunimasa
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2010, 15 : 497 - 499
  • [9] RETREATMENT OF RECURRENT MALIGNANT PLEURAL MESOTHELIOMA WITH CISPLATIN AND PEMETREXED
    Hayashi, Hidetoshi
    Okamoto, Isamu
    Miyazaki, Masaki
    Ichikawa, Yasuko
    Yoshioka, Hiroshige
    Kunimasa, Kei
    Tanaka, Kaoru
    Okamoto, Kunio
    Makimura, Chihiro
    Iwasaku, Masahiro
    Nisiyama, Akihiro
    Korogi, Yohhei
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [10] Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed
    Hayashi, Hidetoshi
    Okamoto, Isamu
    Ichikawa, Yasuko
    Miyazaki, Masaki
    Yoshioka, Hiroshige
    Kunimasa, Kei
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 497 - 499
12345